Mohamed Labedi, MD

Assistant Professor, Cardiology, Department of Internal Medicine
Cardiology

    About me

    Videos

    Remote video URL

    Gender

    Male

    Languages spoken

    Arabic

    Education & training

    Board Certifications
    Cardiovascular Disease
    Clinical Cardiac Electrophysiology
    Medical School
    Benghazi University School of Medicine, Benghazi, Libya
    Residency
    University at Buffalo, Buffalo, NY
    Fellowship
    University of Utah School of Medicine, Salt Lake City, UT

    Publications

    1. Mohamed Labedi, Nassir Marrouche. Invasive treatment of atrial fibrillation (review paper). Curr Opin Cardiol. 2016 Jul;31(4):366-73.

    2. Traina MI, Sanchez DR, Hernandez S, Bradfield JS, Labedi MR, Ngab TA, Steurer F, Montgomery SP, Meymandi SK. Prevalence and Impact of Chagas Disease Among Latin American Immigrants With Nonischemic Cardiomyopathy in Los Angeles, California. Circ Heart Fail. 2015 Sep;8(5):938-43.  

    3. Wever-Pinzon O, Selzman CH, Drakos SG, Saidi A, Stoddard GJ, Gilbert EM, Labedi M, Reid BB, Davis ES, Kfoury AG, Li DY, Stehlik J, Bader F. Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circ Heart Fail. 2013 May;6(3):517-26

    4. Mohamed Labedi, Rami Alharethi, AG Kfoury, Deborah Budge, Bruce Reid, Brad Rasmusson, T. Jared Bunch. Electromagnetic Interference of Automatic Implantable Cardioverter Defibrillators and HeartWare Left Ventricular Assist Device.  ASAIO J. 2013 Mar-Apr;59(2):136-9. 

    5. Josef Stehlik MD, Mohamed Labedi MD, Dylan Miller MD, Monica P Revelo MD. Abnormal finding on a screening endomyocardial biopsy. American Journal of Transplantation. 2012 Feb; 12(2):500.

    6. Boden WE, O'Rourke RA, Teo KK, Maron DJ, Hartigan PM, Sedlis SP, Dada M, Mohamed Labedi, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS; COURAGE Trial Investigators. Impact of optimal medical therapy with PCI or without PCI on long-term cardiovascular endpoints in patients with stable coronary artery disease. Am J Cardiol. 2009 Jul 1; 104(1).

    7. Sheba K. Meymandi, Mahmoud  Traina, Atef El-Gassier, Tarik Ngab, Mohamed Labedi, Robin Y. Wachsner, Prevalence of Chagas Disease in US Latin American Immigrant Population with Cardiomyopathy. Journal of Cardiac Failure. 2008 Mar; 14(6s Supply 2008): 272.   

    Abstracts

    1. King JB, Labedi M, White R1, Chelu MG, Kaur G, Johnson K, Pacchia C, Marrouche. fibrillation on left atrial fibrosis progression. Presented in ACC 2016 Impact of individual components of the CHA2DS2-VASc score compared with atrial

    2. King JB, Labedi M, White R, Chelu M, Kaur, Johnson K, Pacchia C, Marrouche. Associations between CHA2DS2-VASc and degree of atrial fibrosis. Presented in ACC 2016.  

    3. Mohamed Labedi, Robert White, Jordan King, Christina Frances Pacchia, Kara Johnson, Gagandeep Kaur, Joshua Cates, Alan Morris, Nassir Marrouche. Atrial Fibrosis Progression in Patients with Atrial Fibrillation. Presented in Society of cardiac MRI Jan 2016

    4. Mohamed Labedi, Abdulmohsin Ahmadjee, Matthias Koopman, Nassir Marrouche, Brent Wilson, Nazem Akoum. Atrial fibrosis is associated with higher DC cardioversion failure rates in persistent atrial fibrillation. AHA meeting Orlando, Florida 2015.

    5. Mohamed Labedi, Omar Wever-Pinzon, Feras Qaqa, Rami Alharethi, Abdulfattah Saidi, Stavros Drakos, Edward M. Gilbert, Craig Selzman, Deborah Budge, Bruce Reid, Josef Stehlik, Abdallah Kfoury, Feras Bader. Clinical Predictors and Risks Factors for Left Ventricular Assist Device Thrombosis in HeartMate II Supported Patients. Journal of Heart and Lung transplantation. Volume 31, issue four, s158 4/2012.

    6. Abdulfattah Saidi, Omar Wever-Pinzon, Mohamed Labedi, Michel Barakat, Josef Stehlik, Stavros Drakos, Craig Selzman, Bruce Reid, Rami Alharethi, Abdallah G Kfoury, MD and Feras Bader. Is Improvement in Pulmonary Vascular Hemodynamics in Patients Supported With Continuous-Flow Left Ventricular Assist Devices Sustained After Heart Transplantation? Journal of Heart and Lung transplantation, Volume 31, issue four, s152 April/2012

    7. Ledford, Mohamed Labedi, A.G. Kfoury, J. Stehlik, R. Alharethi, B. Reid, C. Selzman, Revelo, Stoker, F. Bader, D. Miller. Thrombus within heartmateII left ventricular device: Are all clots equal? Journal of Heart and lung Transplantation     Volume 31, issue Four, suppl. s85-s86 April/2012.

    8. Wever-Pinzon O, Saidi A, Mehta N, Selzman CH, Drakos SG, Alharethi R, Gilbert EM, Mohamed Labedi, Budge D, Reid B, Kfoury A, Stehlik J, Bader F.  Reduced Pulsatility in Patients Supported with the Continuous-Flow Left Ventricular Assist Device HeartMate II Is Associated with Increased Bleeding Events.  Journal of Heart and Lung Transplantation 4/2012; 31(4):S33.

    9. Rasmusson K, Brunisholz K, Mohamed Labedi, Knight S, Budge D, Stehlik J, Alharethi R, Nixon J, Frampton S, Kfoury A. Predictors of Graft Survival in Heart Transplant Recipients with Peripartum Cardiomyopathy: Insights from the United Network for Organ Sharing (UNOS) Database, Journal of Heart and Lung Transplantation, volume 31, issue four, s137, 4/2012.

    10. Mohamed R. Labedi, Rami Alharethi, AG Kfoury, Deborah Budge, Bruce Reid, Brad Rasmusson, T. Jared Bunch.  Electromagnetic Interference of Automatic Implantable Cardioverter Defibrillators and HeartWare Left Ventricular Assist Device. Heart Rhythm Society of America 5/2012.

    11. Sheba K. Meymandi, Mahmoud I. Traina, Mark McDonnell, Atef H. El Gassier, Mohamed R. Labedi, Tarik A. Ngab, Robin Y. Wachsner. A Highly Purified Omega-3 Fatty Acid Derivative Does Not Alter QTc Interval but Does Reduce QT Dispersion in Patients with Stable Coronary Artery Disease. Abstract JACC 1029-114 3/11/2008

    12. Sheba K. Meymandi, Mahmoud  Traina, Atef El-Gassier, Tarik Ngab, Mohamed Labedi, Robin Y. Wachsner, Prevalence of Chagas Disease in US Latin American Immigrant Population with Cardiomyopathy. Journal of Cardiac Failure. 2008 Mar; 14(6s Supply 2008): 272. Poster presented at Heart Failure Society of America meeting 2008, Ontario, Canada.